Selected research
Industry Research
Point-of-care Testing Solution Industry Research Report 2026
Market perspective
The global Point-of-care Testing Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Point-of-care Testing Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Point-of-care Testing Solution is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Point-of-care Testing Solution is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Point-of-care Testing Solution include Roche Diagnostics, Abbott, Johnson & Johnson, Siemens Healthineers, Danaher (Beckman Coulter), Ascensia, Sinocare, BioMérieux and QuidelOrtho, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Point-of-care Testing Solution market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Point-of-care Testing Solution Market by Company
Roche Diagnostics
Abbott
Johnson & Johnson
Siemens Healthineers
Danaher (Beckman Coulter)
Ascensia
Sinocare
BioMérieux
QuidelOrtho
BD
Nova Biomedical
Werfen
Chembio Diagnostics
Trinity Biotech
Thermo Fisher Scientific
SD Biosensor
Snibe Diagnostics
Wondfo
Yuwell
Runda Medical
Lepu Medical
Getein Biotech
Kehua Bio-engineering
Wuhan EasyDiagnosis Biomedicine
Anda Gene
Point-of-care Testing Solution Segment by Type
Electrochemical Type
Optical Type
Molecular Diagnostics Type
Point-of-care Testing Solution Segment by Application
Hospital
Clinic
R&D
Others
Point-of-care Testing Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-care Testing Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-care Testing Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-care Testing Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-of-care Testing Solution manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-of-care Testing Solution by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-of-care Testing Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Electrochemical Type
- Optical Type
- Molecular Diagnostics Type
Applications
- Hospital
- Clinic
- R&D
- Others
Companies covered
- Roche Diagnostics
- Abbott
- Johnson & Johnson
- Siemens Healthineers
- Danaher (Beckman Coulter)
- Ascensia
- Sinocare
- BioMérieux
- QuidelOrtho
- BD
- Nova Biomedical
- Werfen
- Chembio Diagnostics
- Trinity Biotech
- Thermo Fisher Scientific
- SD Biosensor
- Snibe Diagnostics
- Wondfo
- Yuwell
- Runda Medical
- Lepu Medical
- Getein Biotech
- Kehua Bio-engineering
- Wuhan EasyDiagnosis Biomedicine
- Anda Gene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Point-of-care Testing Solution Market Size (2021-2032)
- 2.2.2 Global Point-of-care Testing Solution Sales (2021-2032)
- 2.2.3 Global Point-of-care Testing Solution Market Average Price (2021-2032)
- 2.3 Point-of-care Testing Solution by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Electrochemical Type
- 2.3.3 Optical Type
- 2.3.4 Molecular Diagnostics Type
- 2.4 Point-of-care Testing Solution by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 R&D
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Point-of-care Testing Solution Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Point-of-care Testing Solution Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Point-of-care Testing Solution Revenue of Manufacturers (2021-2026)
- 3.4 Global Point-of-care Testing Solution Average Price by Manufacturers (2021-2026)
- 3.5 Global Point-of-care Testing Solution Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Point-of-care Testing Solution, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Point-of-care Testing Solution, Product Type & Application
- 3.8 Global Manufacturers of Point-of-care Testing Solution, Established Date
- 3.9 Global Point-of-care Testing Solution Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche Diagnostics
- 4.1.1 Roche Diagnostics Company Information
- 4.1.2 Roche Diagnostics Business Overview
- 4.1.3 Roche Diagnostics Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche Diagnostics Point-of-care Testing Solution Product Portfolio
- 4.1.5 Roche Diagnostics Recent Developments
- 4.2 Abbott
- 4.2.1 Abbott Company Information
- 4.2.2 Abbott Business Overview
- 4.2.3 Abbott Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abbott Point-of-care Testing Solution Product Portfolio
- 4.2.5 Abbott Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Point-of-care Testing Solution Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
- 4.4 Siemens Healthineers
- 4.4.1 Siemens Healthineers Company Information
- 4.4.2 Siemens Healthineers Business Overview
- 4.4.3 Siemens Healthineers Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Siemens Healthineers Point-of-care Testing Solution Product Portfolio
- 4.4.5 Siemens Healthineers Recent Developments
- 4.5 Danaher (Beckman Coulter)
- 4.5.1 Danaher (Beckman Coulter) Company Information
- 4.5.2 Danaher (Beckman Coulter) Business Overview
- 4.5.3 Danaher (Beckman Coulter) Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Danaher (Beckman Coulter) Point-of-care Testing Solution Product Portfolio
- 4.5.5 Danaher (Beckman Coulter) Recent Developments
- 4.6 Ascensia
- 4.6.1 Ascensia Company Information
- 4.6.2 Ascensia Business Overview
- 4.6.3 Ascensia Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ascensia Point-of-care Testing Solution Product Portfolio
- 4.6.5 Ascensia Recent Developments
- 4.7 Sinocare
- 4.7.1 Sinocare Company Information
- 4.7.2 Sinocare Business Overview
- 4.7.3 Sinocare Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sinocare Point-of-care Testing Solution Product Portfolio
- 4.7.5 Sinocare Recent Developments
- 4.8 BioMérieux
- 4.8.1 BioMérieux Company Information
- 4.8.2 BioMérieux Business Overview
- 4.8.3 BioMérieux Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BioMérieux Point-of-care Testing Solution Product Portfolio
- 4.8.5 BioMérieux Recent Developments
- 4.9 QuidelOrtho
- 4.9.1 QuidelOrtho Company Information
- 4.9.2 QuidelOrtho Business Overview
- 4.9.3 QuidelOrtho Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 QuidelOrtho Point-of-care Testing Solution Product Portfolio
- 4.9.5 QuidelOrtho Recent Developments
- 4.10 BD
- 4.10.1 BD Company Information
- 4.10.2 BD Business Overview
- 4.10.3 BD Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BD Point-of-care Testing Solution Product Portfolio
- 4.10.5 BD Recent Developments
- 4.11 Nova Biomedical
- 4.11.1 Nova Biomedical Company Information
- 4.11.2 Nova Biomedical Business Overview
- 4.11.3 Nova Biomedical Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nova Biomedical Point-of-care Testing Solution Product Portfolio
- 4.11.5 Nova Biomedical Recent Developments
- 4.12 Werfen
- 4.12.1 Werfen Company Information
- 4.12.2 Werfen Business Overview
- 4.12.3 Werfen Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Werfen Point-of-care Testing Solution Product Portfolio
- 4.12.5 Werfen Recent Developments
- 4.13 Chembio Diagnostics
- 4.13.1 Chembio Diagnostics Company Information
- 4.13.2 Chembio Diagnostics Business Overview
- 4.13.3 Chembio Diagnostics Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chembio Diagnostics Point-of-care Testing Solution Product Portfolio
- 4.13.5 Chembio Diagnostics Recent Developments
- 4.14 Trinity Biotech
- 4.14.1 Trinity Biotech Company Information
- 4.14.2 Trinity Biotech Business Overview
- 4.14.3 Trinity Biotech Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Trinity Biotech Point-of-care Testing Solution Product Portfolio
- 4.14.5 Trinity Biotech Recent Developments
- 4.15 Thermo Fisher Scientific
- 4.15.1 Thermo Fisher Scientific Company Information
- 4.15.2 Thermo Fisher Scientific Business Overview
- 4.15.3 Thermo Fisher Scientific Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Thermo Fisher Scientific Point-of-care Testing Solution Product Portfolio
- 4.15.5 Thermo Fisher Scientific Recent Developments
- 4.16 SD Biosensor
- 4.16.1 SD Biosensor Company Information
- 4.16.2 SD Biosensor Business Overview
- 4.16.3 SD Biosensor Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 SD Biosensor Point-of-care Testing Solution Product Portfolio
- 4.16.5 SD Biosensor Recent Developments
- 4.17 Snibe Diagnostics
- 4.17.1 Snibe Diagnostics Company Information
- 4.17.2 Snibe Diagnostics Business Overview
- 4.17.3 Snibe Diagnostics Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Snibe Diagnostics Point-of-care Testing Solution Product Portfolio
- 4.17.5 Snibe Diagnostics Recent Developments
- 4.18 Wondfo
- 4.18.1 Wondfo Company Information
- 4.18.2 Wondfo Business Overview
- 4.18.3 Wondfo Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Wondfo Point-of-care Testing Solution Product Portfolio
- 4.18.5 Wondfo Recent Developments
- 4.19 Yuwell
- 4.19.1 Yuwell Company Information
- 4.19.2 Yuwell Business Overview
- 4.19.3 Yuwell Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Yuwell Point-of-care Testing Solution Product Portfolio
- 4.19.5 Yuwell Recent Developments
- 4.20 Runda Medical
- 4.20.1 Runda Medical Company Information
- 4.20.2 Runda Medical Business Overview
- 4.20.3 Runda Medical Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Runda Medical Point-of-care Testing Solution Product Portfolio
- 4.20.5 Runda Medical Recent Developments
- 4.21 Lepu Medical
- 4.21.1 Lepu Medical Company Information
- 4.21.2 Lepu Medical Business Overview
- 4.21.3 Lepu Medical Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Lepu Medical Point-of-care Testing Solution Product Portfolio
- 4.21.5 Lepu Medical Recent Developments
- 4.22 Getein Biotech
- 4.22.1 Getein Biotech Company Information
- 4.22.2 Getein Biotech Business Overview
- 4.22.3 Getein Biotech Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Getein Biotech Point-of-care Testing Solution Product Portfolio
- 4.22.5 Getein Biotech Recent Developments
- 4.23 Kehua Bio-engineering
- 4.23.1 Kehua Bio-engineering Company Information
- 4.23.2 Kehua Bio-engineering Business Overview
- 4.23.3 Kehua Bio-engineering Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Kehua Bio-engineering Point-of-care Testing Solution Product Portfolio
- 4.23.5 Kehua Bio-engineering Recent Developments
- 4.24 Wuhan EasyDiagnosis Biomedicine
- 4.24.1 Wuhan EasyDiagnosis Biomedicine Company Information
- 4.24.2 Wuhan EasyDiagnosis Biomedicine Business Overview
- 4.24.3 Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 Wuhan EasyDiagnosis Biomedicine Point-of-care Testing Solution Product Portfolio
- 4.24.5 Wuhan EasyDiagnosis Biomedicine Recent Developments
- 4.25 Anda Gene
- 4.25.1 Anda Gene Company Information
- 4.25.2 Anda Gene Business Overview
- 4.25.3 Anda Gene Point-of-care Testing Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.25.4 Anda Gene Point-of-care Testing Solution Product Portfolio
- 4.25.5 Anda Gene Recent Developments
5 Global Point-of-care Testing Solution Market Scenario by Region
- 5.1 Global Point-of-care Testing Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Point-of-care Testing Solution Sales by Region: 2021-2032
- 5.2.1 Global Point-of-care Testing Solution Sales by Region: 2021-2026
- 5.2.2 Global Point-of-care Testing Solution Sales by Region: 2027-2032
- 5.3 Global Point-of-care Testing Solution Revenue by Region: 2021-2032
- 5.3.1 Global Point-of-care Testing Solution Revenue by Region: 2021-2026
- 5.3.2 Global Point-of-care Testing Solution Revenue by Region: 2027-2032
- 5.4 North America Point-of-care Testing Solution Market Facts & Figures by Country
- 5.4.1 North America Point-of-care Testing Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Point-of-care Testing Solution Sales by Country (2021-2032)
- 5.4.3 North America Point-of-care Testing Solution Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Point-of-care Testing Solution Market Facts & Figures by Country
- 5.5.1 Europe Point-of-care Testing Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Point-of-care Testing Solution Sales by Country (2021-2032)
- 5.5.3 Europe Point-of-care Testing Solution Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Point-of-care Testing Solution Market Facts & Figures by Country
- 5.6.1 Asia Pacific Point-of-care Testing Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Point-of-care Testing Solution Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Point-of-care Testing Solution Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Point-of-care Testing Solution Market Facts & Figures by Country
- 5.7.1 South America Point-of-care Testing Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Point-of-care Testing Solution Sales by Country (2021-2032)
- 5.7.3 South America Point-of-care Testing Solution Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Point-of-care Testing Solution Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Point-of-care Testing Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Point-of-care Testing Solution Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Point-of-care Testing Solution Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Point-of-care Testing Solution Sales by Type (2021-2032)
- 6.1.1 Global Point-of-care Testing Solution Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Point-of-care Testing Solution Sales Market Share by Type (2021-2032)
- 6.2 Global Point-of-care Testing Solution Revenue by Type (2021-2032)
- 6.2.1 Global Point-of-care Testing Solution Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Point-of-care Testing Solution Revenue Market Share by Type (2021-2032)
- 6.3 Global Point-of-care Testing Solution Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Point-of-care Testing Solution Sales by Application (2021-2032)
- 7.1.1 Global Point-of-care Testing Solution Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Point-of-care Testing Solution Sales Market Share by Application (2021-2032)
- 7.2 Global Point-of-care Testing Solution Revenue by Application (2021-2032)
- 7.2.1 Global Point-of-care Testing Solution Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Point-of-care Testing Solution Revenue Market Share by Application (2021-2032)
- 7.3 Global Point-of-care Testing Solution Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Point-of-care Testing Solution Value Chain Analysis
- 8.1.1 Point-of-care Testing Solution Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Point-of-care Testing Solution Production Mode & Process
- 8.2 Point-of-care Testing Solution Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Point-of-care Testing Solution Distributors
- 8.2.3 Point-of-care Testing Solution Customers
9 Global Point-of-care Testing Solution Analyzing Market Dynamics
- 9.1 Point-of-care Testing Solution Industry Trends
- 9.2 Point-of-care Testing Solution Industry Drivers
- 9.3 Point-of-care Testing Solution Industry Opportunities and Challenges
- 9.4 Point-of-care Testing Solution Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst